Merck & Co Inc XNYS: MRK

Strong Performer

Download real time

92.92 -0.01 (-0.01%)

26.75% Gain from 52W Low

19.4M

XNYS Volume

XNYS 14 Nov, 2025 4:30 PM (EST)

Acquisition Plans

Merck reportedly nears a $9.2 bn deal to acquire Cidara Therapeutics to expand its drug portfolio See details

Merck & Co Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents